Dr. John C. Reed is a President & Director at Synthorx, Inc. and a Head-Global Research & Development at Sanofi.
He is on the Board of Directors at Synthorx, Inc. and BIOCOM. Dr. Reed was previously employed as a Head-Roche Pharma Research & Early Development by Roche Holding AG, an Independent Director by Clovis Oncology, Inc., a Founder by Apoptos, Inc., an Independent Director by Isis Pharmaceuticals, Inc., an Associate Member by Whitaker Institute of Biomedical Engineering, a Co-Founder by Idun Pharmaceuticals, Inc., an Associate Member by University of California San Diego, a President, Chief Executive Officer & Professor by Burnham Institute for Medical Research, and an Assistant Director by University of Pennsylvania.
He also served on the board at Repros Therapeutics, Inc., Pharmion Corp., CONNECT and Stratagene Corp.
He received his undergraduate degree from the University of Virginia and a doctorate degree from Perelman School of Medicine.